Merck & Co.
E106451
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
All labels observed (9)
| Label | Occurrences |
|---|---|
| Merck & Co. canonical | 13 |
| Merck Sharp & Dohme | 2 |
| MSD (Merck Sharp & Dohme) | 1 |
| Merck | 1 |
| Merck & Co., Inc. | 1 |
| Merck & Co., Inc., Rahway, NJ, USA | 1 |
| Merck Animal Health | 1 |
| Merck Research Laboratories | 1 |
| Merck Sharp & Dohme Corp. | 1 |
Statements (60)
| Predicate | Object |
|---|---|
| instanceOf |
multinational corporation
ⓘ
pharmaceutical company ⓘ public company ⓘ |
| alternativeName |
Merck & Co.
ⓘ
surface form:
Merck & Co., Inc.
Merck & Co. ⓘ
surface form:
Merck & Co., Inc., Rahway, NJ, USA
|
| alternativeNameOutsideUSAndCanada | MSD ⓘ |
| brandName |
MSD
ⓘ
Merck & Co. self-linksurface differs ⓘ
surface form:
Merck Sharp & Dohme
|
| businessModel | research-based pharmaceutical company ⓘ |
| CEO | Robert M. Davis ⓘ |
| chairperson | Robert M. Davis ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| focusArea |
animal health
ⓘ
cardiometabolic diseases ⓘ immunology ⓘ infectious diseases ⓘ oncology ⓘ vaccinology ⓘ |
| formerHeadquartersLocation |
Kenilworth, New Jersey
ⓘ
surface form:
Kenilworth, New Jersey, United States
|
| foundedBy | George Merck ⓘ |
| hasDivision |
Animal Health
ⓘ
Human Health ⓘ Manufacturing ⓘ Research & Development ⓘ |
| hasSubsidiary |
Merck & Co.
self-linksurface differs
ⓘ
surface form:
Merck Animal Health
Organon & Co. (historical, later spun off) ⓘ |
| headquartersLocation |
Rahway, New Jersey
ⓘ
surface form:
Rahway, New Jersey, United States
|
| inception | 1891 ⓘ |
| industry |
biotechnology
ⓘ
healthcare ⓘ pharmaceuticals ⓘ |
| ISIN | US58933Y1055 ⓘ |
| legalSeparationFromMerckKGaA | World War I era ⓘ |
| listedInIndex |
Dow Jones Industrial Average
ⓘ
S&P 500 Index ⓘ
surface form:
S&P 500
|
| notableDrug |
Gardasil
ⓘ
Gardasil ⓘ
surface form:
Gardasil 9
Isentress ⓘ Januvia ⓘ Keytruda ⓘ Propecia ⓘ Singulair ⓘ Zetia ⓘ |
| operatesInArea | global ⓘ |
| parentOrganizationHistory | originated as the U.S. subsidiary of Merck KGaA ⓘ |
| primaryProduct |
animal health products
ⓘ
antiviral drugs ⓘ cardiovascular drugs ⓘ diabetes treatments ⓘ oncology drugs ⓘ vaccines ⓘ |
| R&DInvestmentFocus |
animal health products
ⓘ
biologic therapies ⓘ innovative prescription medicines ⓘ vaccines ⓘ |
| researchDivision |
Merck & Co.
self-linksurface differs
ⓘ
surface form:
Merck Research Laboratories
|
| spinoffDate | 2021 ⓘ |
| spunOff |
Organon & Co. (historical, later spun off)
ⓘ
surface form:
Organon & Co.
|
| stockExchange | New York Stock Exchange ⓘ |
| tickerSymbol | MRK ⓘ |
Referenced by (22)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Merck Sharp & Dohme
this entity surface form:
Merck Research Laboratories
this entity surface form:
Merck Animal Health
this entity surface form:
Merck & Co., Inc.
this entity surface form:
Merck & Co., Inc., Rahway, NJ, USA
this entity surface form:
MSD (Merck Sharp & Dohme)
Decision to provide ivermectin (Mectizan) free of charge for river blindness
→
madeBy
→
Merck & Co.
ⓘ
this entity surface form:
Merck Sharp & Dohme
this entity surface form:
Merck
this entity surface form:
Merck Sharp & Dohme Corp.